

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 7.08563538 |
| 2 | positive regulation by symbiont of host defense response (GO:0052509) | 6.75693392 |
| 3 | modulation by symbiont of host defense response (GO:0052031) | 6.75693392 |
| 4 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.75693392 |
| 5 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.75693392 |
| 6 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.75693392 |
| 7 | modulation by symbiont of host immune response (GO:0052553) | 6.75693392 |
| 8 | microglial cell activation (GO:0001774) | 6.64242625 |
| 9 | macrophage activation involved in immune response (GO:0002281) | 6.45203555 |
| 10 | regulation of interferon-beta biosynthetic process (GO:0045357) | 6.22437275 |
| 11 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.89507401 |
| 12 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.73886016 |
| 13 | neutrophil activation involved in immune response (GO:0002283) | 5.26783374 |
| 14 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 5.23317931 |
| 15 | purine deoxyribonucleotide catabolic process (GO:0009155) | 5.21893945 |
| 16 | negative regulation of B cell apoptotic process (GO:0002903) | 5.20823633 |
| 17 | positive regulation of interferon-alpha production (GO:0032727) | 5.01682462 |
| 18 | immunoglobulin mediated immune response (GO:0016064) | 4.85775011 |
| 19 | regulation of interferon-alpha production (GO:0032647) | 4.79028613 |
| 20 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 4.69254626 |
| 21 | macrophage activation (GO:0042116) | 4.66851994 |
| 22 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 4.59748549 |
| 23 | positive thymic T cell selection (GO:0045059) | 4.50457322 |
| 24 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 4.46843354 |
| 25 | positive regulation of B cell differentiation (GO:0045579) | 4.44550915 |
| 26 | respiratory burst (GO:0045730) | 4.43819544 |
| 27 | mature B cell differentiation involved in immune response (GO:0002313) | 4.43647597 |
| 28 | deoxyribonucleotide catabolic process (GO:0009264) | 4.41079854 |
| 29 | myeloid cell activation involved in immune response (GO:0002275) | 4.36080011 |
| 30 | regulation of growth of symbiont in host (GO:0044126) | 4.35116707 |
| 31 | negative regulation of growth of symbiont in host (GO:0044130) | 4.35116707 |
| 32 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 4.35116707 |
| 33 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 4.35116707 |
| 34 | response to peptidoglycan (GO:0032494) | 4.34622309 |
| 35 | regulation of germinal center formation (GO:0002634) | 4.29059563 |
| 36 | response to host immune response (GO:0052572) | 4.24948146 |
| 37 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.24948146 |
| 38 | response to protozoan (GO:0001562) | 4.24337792 |
| 39 | deoxyribose phosphate catabolic process (GO:0046386) | 4.21945205 |
| 40 | positive regulation of antigen processing and presentation (GO:0002579) | 4.19493708 |
| 41 | response to host (GO:0075136) | 4.12139540 |
| 42 | response to host defenses (GO:0052200) | 4.12139540 |
| 43 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 4.12139540 |
| 44 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.07013278 |
| 45 | regulation of B cell differentiation (GO:0045577) | 3.99429180 |
| 46 | B cell receptor signaling pathway (GO:0050853) | 3.98643986 |
| 47 | regulation of B cell apoptotic process (GO:0002902) | 3.94584399 |
| 48 | autophagic vacuole fusion (GO:0000046) | 3.92520817 |
| 49 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 3.92360219 |
| 50 | Peyers patch development (GO:0048541) | 3.85602872 |
| 51 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.85602872 |
| 52 | adenosine receptor signaling pathway (GO:0001973) | 3.83255968 |
| 53 | glycosphingolipid catabolic process (GO:0046479) | 3.81790508 |
| 54 | negative regulation of granulocyte differentiation (GO:0030853) | 3.72831183 |
| 55 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.72403099 |
| 56 | neutrophil activation (GO:0042119) | 3.71999610 |
| 57 | regulation of mast cell degranulation (GO:0043304) | 3.71349575 |
| 58 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.69432844 |
| 59 | granulocyte activation (GO:0036230) | 3.67430883 |
| 60 | I-kappaB phosphorylation (GO:0007252) | 3.65249242 |
| 61 | purinergic receptor signaling pathway (GO:0035587) | 3.64442015 |
| 62 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 3.63394332 |
| 63 | negative thymic T cell selection (GO:0045060) | 3.61036649 |
| 64 | response to muramyl dipeptide (GO:0032495) | 3.60267504 |
| 65 | pinocytosis (GO:0006907) | 3.59720530 |
| 66 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.59341329 |
| 67 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.57985237 |
| 68 | positive regulation of interferon-beta production (GO:0032728) | 3.54143247 |
| 69 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.53979960 |
| 70 | mature B cell differentiation (GO:0002335) | 3.52270833 |
| 71 | positive regulation of mast cell activation (GO:0033005) | 3.51616362 |
| 72 | detection of bacterium (GO:0016045) | 3.50525447 |
| 73 | regulation of antigen processing and presentation (GO:0002577) | 3.49575628 |
| 74 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.45931301 |
| 75 | cellular extravasation (GO:0045123) | 3.44389283 |
| 76 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.43438503 |
| 77 | purine deoxyribonucleotide metabolic process (GO:0009151) | 3.42175554 |
| 78 | positive regulation of mast cell degranulation (GO:0043306) | 3.42035282 |
| 79 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.42035282 |
| 80 | purine nucleotide salvage (GO:0032261) | 3.41433111 |
| 81 | B cell mediated immunity (GO:0019724) | 3.40969620 |
| 82 | glycolipid catabolic process (GO:0019377) | 3.39708629 |
| 83 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 3.39413912 |
| 84 | regulation of mast cell activation (GO:0033003) | 3.39003184 |
| 85 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.35480241 |
| 86 | hyaluronan catabolic process (GO:0030214) | 3.34832678 |
| 87 | detection of other organism (GO:0098543) | 3.33465097 |
| 88 | myeloid leukocyte activation (GO:0002274) | 3.32836813 |
| 89 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.32459998 |
| 90 | positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261) | 3.30279542 |
| 91 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.29081422 |
| 92 | negative T cell selection (GO:0043383) | 3.26993348 |
| 93 | positive regulation of neutrophil migration (GO:1902624) | 3.26048215 |
| 94 | positive regulation of neutrophil chemotaxis (GO:0090023) | 3.26048215 |
| 95 | histamine secretion (GO:0001821) | 3.25761818 |
| 96 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.25243631 |
| 97 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.23041673 |
| 98 | positive regulation of macrophage cytokine production (GO:0060907) | 3.22406870 |
| 99 | regulation of monocyte differentiation (GO:0045655) | 3.21075985 |
| 100 | cellular response to interferon-beta (GO:0035458) | 3.20730875 |
| 101 | mast cell activation (GO:0045576) | 3.20636579 |
| 102 | positive T cell selection (GO:0043368) | 3.19920507 |
| 103 | pyrimidine nucleotide catabolic process (GO:0006244) | 3.19893659 |
| 104 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.17174368 |
| 105 | 2-deoxyribonucleotide metabolic process (GO:0009394) | 3.15603257 |
| 106 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.13607611 |
| 107 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.13607611 |
| 108 | regulation of hypersensitivity (GO:0002883) | 3.13282535 |
| 109 | positive regulation of B cell activation (GO:0050871) | 3.13110012 |
| 110 | positive regulation of B cell proliferation (GO:0030890) | 3.12448331 |
| 111 | leukocyte mediated cytotoxicity (GO:0001909) | 3.11930932 |
| 112 | negative regulation of B cell proliferation (GO:0030889) | 3.11864400 |
| 113 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.09653003 |
| 114 | tolerance induction (GO:0002507) | 3.09204021 |
| 115 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.08548735 |
| 116 | regulation of leukocyte degranulation (GO:0043300) | 3.08533022 |
| 117 | deoxyribose phosphate biosynthetic process (GO:0046385) | 3.08241683 |
| 118 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 3.08241683 |
| 119 | deoxyribose phosphate metabolic process (GO:0019692) | 3.06998229 |
| 120 | ceramide catabolic process (GO:0046514) | 3.06882523 |
| 121 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.06860889 |
| 122 | cellular response to exogenous dsRNA (GO:0071360) | 3.05698100 |
| 123 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.03900997 |
| 124 | negative regulation of cell killing (GO:0031342) | 3.03900997 |
| 125 | negative regulation of mast cell activation (GO:0033004) | 3.03630351 |
| 126 | establishment of viral latency (GO:0019043) | 3.02762723 |
| 127 | regulation of monocyte chemotaxis (GO:0090025) | 3.01317344 |
| 128 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.01182057 |
| 129 | positive regulation of protein homooligomerization (GO:0032464) | 2.99509644 |
| 130 | myeloid dendritic cell activation (GO:0001773) | 2.99028723 |
| 131 | negative regulation of norepinephrine secretion (GO:0010700) | 2.98621521 |
| 132 | nucleotide salvage (GO:0043173) | 2.98070198 |
| 133 | cellular response to zinc ion (GO:0071294) | 2.97130654 |
| 134 | negative regulation of interleukin-6 production (GO:0032715) | 2.96145258 |
| 135 | macrophage chemotaxis (GO:0048246) | 2.96047474 |
| 136 | germinal center formation (GO:0002467) | 2.94957363 |
| 137 | negative regulation of phagocytosis (GO:0050765) | 2.94053479 |
| 138 | defense response to protozoan (GO:0042832) | 2.91600288 |
| 139 | positive regulation of chemokine secretion (GO:0090197) | 2.89520673 |
| 140 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.89106872 |
| 141 | type I interferon signaling pathway (GO:0060337) | 2.86253341 |
| 142 | cellular response to type I interferon (GO:0071357) | 2.86253341 |
| 143 | response to type I interferon (GO:0034340) | 2.82809507 |
| 144 | neutrophil mediated immunity (GO:0002446) | 2.80890764 |
| 145 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.79371667 |
| 146 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.79287218 |
| 147 | positive regulation of leukocyte degranulation (GO:0043302) | 2.76933695 |
| 148 | myeloid dendritic cell differentiation (GO:0043011) | 2.73782806 |
| 149 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.72686807 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.90555369 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.36066276 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.92412776 |
| 4 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.90744991 |
| 5 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.47259545 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.97496596 |
| 7 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.83185828 |
| 8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.72277833 |
| 9 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.47680580 |
| 10 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 3.29108396 |
| 11 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.22444197 |
| 12 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.18209927 |
| 13 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.10262334 |
| 14 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.00606587 |
| 15 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.95417706 |
| 16 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.85042897 |
| 17 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.66032275 |
| 18 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.50802613 |
| 19 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.46265132 |
| 20 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.45815554 |
| 21 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.43388871 |
| 22 | CIITA_25753668_ChIP-Seq_RAJI_Human | 2.31521149 |
| 23 | SPI1_23127762_ChIP-Seq_K562_Human | 2.27343776 |
| 24 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.24768796 |
| 25 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.21211001 |
| 26 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.20715530 |
| 27 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.15269211 |
| 28 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.12994559 |
| 29 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 2.10773728 |
| 30 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.03672889 |
| 31 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.03480866 |
| 32 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.03267962 |
| 33 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.01889202 |
| 34 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.98984963 |
| 35 | GATA1_22025678_ChIP-Seq_K562_Human | 1.92074205 |
| 36 | MYB_26560356_Chip-Seq_TH2_Human | 1.90006215 |
| 37 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.82496688 |
| 38 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.78819302 |
| 39 | * MAF_26560356_Chip-Seq_TH1_Human | 1.77446081 |
| 40 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.72706327 |
| 41 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.71982147 |
| 42 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.69274734 |
| 43 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.67968215 |
| 44 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.67487025 |
| 45 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66481915 |
| 46 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.63933374 |
| 47 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.63817888 |
| 48 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.62093074 |
| 49 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.54255489 |
| 50 | MYB_26560356_Chip-Seq_TH1_Human | 1.54151165 |
| 51 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.51472810 |
| 52 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.48540818 |
| 53 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.48140833 |
| 54 | MYC_22102868_ChIP-Seq_BL_Human | 1.43654975 |
| 55 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.42996050 |
| 56 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.41945465 |
| 57 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.41073709 |
| 58 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.40018842 |
| 59 | UTX_26944678_Chip-Seq_JUKART_Human | 1.39382323 |
| 60 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.38468775 |
| 61 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.37554199 |
| 62 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.30979447 |
| 63 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.30779602 |
| 64 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.30533732 |
| 65 | * VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.28401482 |
| 66 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25642597 |
| 67 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.25437470 |
| 68 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.23935425 |
| 69 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.21437100 |
| 70 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.20803273 |
| 71 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.20290394 |
| 72 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.20129095 |
| 73 | GATA3_26560356_Chip-Seq_TH2_Human | 1.19651459 |
| 74 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.19259600 |
| 75 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.18720644 |
| 76 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.18558772 |
| 77 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.17455861 |
| 78 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.16433123 |
| 79 | P68_20966046_ChIP-Seq_HELA_Human | 1.16134555 |
| 80 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.13497264 |
| 81 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.13226420 |
| 82 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.11500880 |
| 83 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.10758283 |
| 84 | * P300_27268052_Chip-Seq_Bcells_Human | 1.10634166 |
| 85 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.10531872 |
| 86 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.09567839 |
| 87 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.09201366 |
| 88 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.08823655 |
| 89 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.07617106 |
| 90 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.03419075 |
| 91 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.03413683 |
| 92 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.03093033 |
| 93 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.02680295 |
| 94 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02665729 |
| 95 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.02329999 |
| 96 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.02118655 |
| 97 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.01947283 |
| 98 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.01645368 |
| 99 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.01566167 |
| 100 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 1.00275537 |
| 101 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.00032907 |
| 102 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99588617 |
| 103 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.99128356 |
| 104 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97600611 |
| 105 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.94794868 |
| 106 | E2F7_22180533_ChIP-Seq_HELA_Human | 0.91578713 |
| 107 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.88967955 |
| 108 | GATA2_19941826_ChIP-Seq_K562_Human | 0.88906388 |
| 109 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.88237373 |
| 110 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.85793474 |
| 111 | MAF_26560356_Chip-Seq_TH2_Human | 0.85392341 |
| 112 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.84106175 |
| 113 | * KDM2B_26808549_Chip-Seq_DND41_Human | 0.84028471 |
| 114 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.82763591 |
| 115 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.82603457 |
| 116 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.82027411 |
| 117 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.79984204 |
| 118 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.78926686 |
| 119 | GATA1_19941826_ChIP-Seq_K562_Human | 0.77333352 |
| 120 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.77020488 |
| 121 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.76470464 |
| 122 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.75442287 |
| 123 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.70730691 |
| 124 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.70338737 |
| 125 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.68747153 |
| 126 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.68528581 |
| 127 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.60220847 |
| 128 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.59222408 |
| 129 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.58399503 |
| 130 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.57754145 |
| 131 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.57391901 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 5.17998978 |
| 2 | MP0005058_abnormal_lysosome_morphology | 4.60314346 |
| 3 | MP0006082_CNS_inflammation | 3.93277980 |
| 4 | MP0003191_abnormal_cellular_cholesterol | 3.56242154 |
| 5 | MP0003303_peritoneal_inflammation | 3.43157039 |
| 6 | MP0003436_decreased_susceptibility_to | 3.35205595 |
| 7 | MP0002148_abnormal_hypersensitivity_rea | 3.20857723 |
| 8 | MP0002419_abnormal_innate_immunity | 3.17175782 |
| 9 | MP0005000_abnormal_immune_tolerance | 3.00092124 |
| 10 | MP0003172_abnormal_lysosome_physiology | 2.93776154 |
| 11 | MP0005671_abnormal_response_to | 2.88825648 |
| 12 | MP0002452_abnormal_antigen_presenting | 2.83245906 |
| 13 | MP0005464_abnormal_platelet_physiology | 2.83206038 |
| 14 | MP0009785_altered_susceptibility_to | 2.76150470 |
| 15 | MP0001800_abnormal_humoral_immune | 2.72213500 |
| 16 | MP0005025_abnormal_response_to | 2.61293541 |
| 17 | MP0001790_abnormal_immune_system | 2.60191169 |
| 18 | MP0005387_immune_system_phenotype | 2.60191169 |
| 19 | MP0002723_abnormal_immune_serum | 2.50107174 |
| 20 | MP0003690_abnormal_glial_cell | 2.42890777 |
| 21 | MP0001819_abnormal_immune_cell | 2.32975969 |
| 22 | MP0002420_abnormal_adaptive_immunity | 2.31741008 |
| 23 | MP0009840_abnormal_foam_cell | 2.31704811 |
| 24 | MP0000685_abnormal_immune_system | 2.26037281 |
| 25 | MP0004510_myositis | 2.20211302 |
| 26 | MP0008057_abnormal_DNA_replication | 2.01823725 |
| 27 | MP0002405_respiratory_system_inflammati | 1.88134570 |
| 28 | MP0001533_abnormal_skeleton_physiology | 1.84566677 |
| 29 | MP0003724_increased_susceptibility_to | 1.83940057 |
| 30 | MP0001845_abnormal_inflammatory_respons | 1.80375317 |
| 31 | MP0003075_altered_response_to | 1.79876542 |
| 32 | MP0001853_heart_inflammation | 1.77346509 |
| 33 | MP0000716_abnormal_immune_system | 1.72970059 |
| 34 | MP0009333_abnormal_splenocyte_physiolog | 1.70199418 |
| 35 | MP0000343_altered_response_to | 1.66709595 |
| 36 | MP0000689_abnormal_spleen_morphology | 1.61821843 |
| 37 | MP0003183_abnormal_peptide_metabolism | 1.60357412 |
| 38 | MP0002398_abnormal_bone_marrow | 1.59940556 |
| 39 | MP0008469_abnormal_protein_level | 1.58327635 |
| 40 | MP0003300_gastrointestinal_ulcer | 1.54979060 |
| 41 | MP0005310_abnormal_salivary_gland | 1.54909339 |
| 42 | MP0010094_abnormal_chromosome_stability | 1.44742773 |
| 43 | MP0010155_abnormal_intestine_physiology | 1.43664746 |
| 44 | MP0004947_skin_inflammation | 1.41654304 |
| 45 | MP0002429_abnormal_blood_cell | 1.40583644 |
| 46 | MP0005166_decreased_susceptibility_to | 1.39606127 |
| 47 | MP0002722_abnormal_immune_system | 1.38715581 |
| 48 | MP0005645_abnormal_hypothalamus_physiol | 1.38231537 |
| 49 | MP0004883_abnormal_blood_vessel | 1.35178196 |
| 50 | MP0000604_amyloidosis | 1.32556749 |
| 51 | MP0006036_abnormal_mitochondrial_physio | 1.32195270 |
| 52 | MP0002019_abnormal_tumor_incidence | 1.31637619 |
| 53 | MP0001986_abnormal_taste_sensitivity | 1.29436116 |
| 54 | MP0009764_decreased_sensitivity_to | 1.28070831 |
| 55 | MP0002998_abnormal_bone_remodeling | 1.25283536 |
| 56 | MP0002166_altered_tumor_susceptibility | 1.25142186 |
| 57 | MP0002009_preneoplasia | 1.19223089 |
| 58 | MP0001851_eye_inflammation | 1.17942841 |
| 59 | MP0005075_abnormal_melanosome_morpholog | 1.17672522 |
| 60 | MP0000465_gastrointestinal_hemorrhage | 1.16905425 |
| 61 | MP0003448_altered_tumor_morphology | 1.14702293 |
| 62 | MP0002006_tumorigenesis | 1.12658999 |
| 63 | MP0010307_abnormal_tumor_latency | 1.12499297 |
| 64 | MP0000569_abnormal_digit_pigmentation | 1.10185065 |
| 65 | MP0001905_abnormal_dopamine_level | 1.06195093 |
| 66 | MP0008058_abnormal_DNA_repair | 1.04994246 |
| 67 | MP0000249_abnormal_blood_vessel | 1.03940348 |
| 68 | MP0002396_abnormal_hematopoietic_system | 1.02557697 |
| 69 | MP0005164_abnormal_response_to | 1.02340874 |
| 70 | MP0002933_joint_inflammation | 1.01752014 |
| 71 | MP0003656_abnormal_erythrocyte_physiolo | 0.98893055 |
| 72 | MP0005220_abnormal_exocrine_pancreas | 0.98742923 |
| 73 | MP0000858_altered_metastatic_potential | 0.97443777 |
| 74 | MP0003828_pulmonary_edema | 0.95465127 |
| 75 | MP0001873_stomach_inflammation | 0.93632857 |
| 76 | MP0005084_abnormal_gallbladder_morpholo | 0.93327778 |
| 77 | MP0009697_abnormal_copulation | 0.93057988 |
| 78 | MP0009278_abnormal_bone_marrow | 0.88812178 |
| 79 | MP0005174_abnormal_tail_pigmentation | 0.87484576 |
| 80 | MP0004782_abnormal_surfactant_physiolog | 0.86503751 |
| 81 | MP0003763_abnormal_thymus_physiology | 0.84176268 |
| 82 | MP0009763_increased_sensitivity_to | 0.83636315 |
| 83 | MP0003111_abnormal_nucleus_morphology | 0.83269464 |
| 84 | MP0005390_skeleton_phenotype | 0.83120570 |
| 85 | MP0005167_abnormal_blood-brain_barrier | 0.82509167 |
| 86 | MP0006035_abnormal_mitochondrial_morpho | 0.82343255 |
| 87 | MP0003566_abnormal_cell_adhesion | 0.80715257 |
| 88 | MP0001545_abnormal_hematopoietic_system | 0.79661283 |
| 89 | MP0005397_hematopoietic_system_phenotyp | 0.79661283 |
| 90 | MP0008260_abnormal_autophagy | 0.79526626 |
| 91 | MP0008004_abnormal_stomach_pH | 0.79276449 |
| 92 | MP0004808_abnormal_hematopoietic_stem | 0.78705217 |
| 93 | MP0002653_abnormal_ependyma_morphology | 0.78564366 |
| 94 | MP0003806_abnormal_nucleotide_metabolis | 0.77196317 |
| 95 | MP0000015_abnormal_ear_pigmentation | 0.77090977 |
| 96 | MP0003252_abnormal_bile_duct | 0.73801099 |
| 97 | MP0002090_abnormal_vision | 0.73792988 |
| 98 | MP0002136_abnormal_kidney_physiology | 0.72401729 |
| 99 | MP0001915_intracranial_hemorrhage | 0.72171762 |
| 100 | MP0001663_abnormal_digestive_system | 0.71976987 |
| 101 | MP0003786_premature_aging | 0.71881856 |
| 102 | MP0005451_abnormal_body_composition | 0.71797192 |
| 103 | MP0003795_abnormal_bone_structure | 0.71754596 |
| 104 | MP0003045_fibrosis | 0.70794752 |
| 105 | MP0001881_abnormal_mammary_gland | 0.70776165 |
| 106 | MP0000681_abnormal_thyroid_gland | 0.70627911 |
| 107 | MP0000920_abnormal_myelination | 0.69013905 |
| 108 | MP0000313_abnormal_cell_death | 0.68418888 |
| 109 | MP0000767_abnormal_smooth_muscle | 0.68341161 |
| 110 | MP0008873_increased_physiological_sensi | 0.67699340 |
| 111 | MP0003787_abnormal_imprinting | 0.67689480 |
| 112 | MP0002132_abnormal_respiratory_system | 0.65944011 |
| 113 | MP0000703_abnormal_thymus_morphology | 0.65713238 |
| 114 | MP0001764_abnormal_homeostasis | 0.65257104 |
| 115 | MP0000609_abnormal_liver_physiology | 0.65150157 |
| 116 | MP0002970_abnormal_white_adipose | 0.63941657 |
| 117 | MP0005319_abnormal_enzyme/_coenzyme | 0.63699445 |
| 118 | MP0005535_abnormal_body_temperature | 0.62727397 |
| 119 | MP0000371_diluted_coat_color | 0.61588302 |
| 120 | MP0005165_increased_susceptibility_to | 0.61466697 |
| 121 | MP0002083_premature_death | 0.60893230 |
| 122 | MP0003866_abnormal_defecation | 0.59541402 |
| 123 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.59446285 |
| 124 | MP0003279_aneurysm | 0.59097402 |
| 125 | MP0005266_abnormal_metabolism | 0.58772984 |
| 126 | MP0008007_abnormal_cellular_replicative | 0.58754840 |
| 127 | MP0005023_abnormal_wound_healing | 0.58517788 |
| 128 | MP0005376_homeostasis/metabolism_phenot | 0.58272006 |
| 129 | MP0000490_abnormal_crypts_of | 0.54543230 |
| 130 | MP0002135_abnormal_kidney_morphology | 0.53197542 |
| 131 | MP0002277_abnormal_respiratory_mucosa | 0.52579795 |
| 132 | MP0002254_reproductive_system_inflammat | 0.52479229 |
| 133 | MP0008438_abnormal_cutaneous_collagen | 0.51952050 |
| 134 | MP0000598_abnormal_liver_morphology | 0.51609066 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 6.97797881 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 6.64952101 |
| 3 | Systemic lupus erythematosus (HP:0002725) | 6.40316952 |
| 4 | Abnormality of glycolipid metabolism (HP:0010969) | 5.51409294 |
| 5 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.51409294 |
| 6 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.51409294 |
| 7 | Eczematoid dermatitis (HP:0000976) | 5.46763546 |
| 8 | Glomerulonephritis (HP:0000099) | 5.10055860 |
| 9 | Vacuolated lymphocytes (HP:0001922) | 5.03608994 |
| 10 | Increased cerebral lipofuscin (HP:0011813) | 4.97299267 |
| 11 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.76740129 |
| 12 | Dysostosis multiplex (HP:0000943) | 4.65188072 |
| 13 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.59219030 |
| 14 | Increased IgE level (HP:0003212) | 4.08040983 |
| 15 | Recurrent skin infections (HP:0001581) | 3.97392237 |
| 16 | Abnormality of macrophages (HP:0004311) | 3.95023365 |
| 17 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.86609122 |
| 18 | Complement deficiency (HP:0004431) | 3.72833271 |
| 19 | B lymphocytopenia (HP:0010976) | 3.72071696 |
| 20 | Abnormality of complement system (HP:0005339) | 3.62995668 |
| 21 | Disinhibition (HP:0000734) | 3.60720854 |
| 22 | Abnormality of B cell number (HP:0010975) | 3.59387967 |
| 23 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.59184764 |
| 24 | Verrucae (HP:0200043) | 3.56084730 |
| 25 | Papilloma (HP:0012740) | 3.56084730 |
| 26 | Cellulitis (HP:0100658) | 3.48012724 |
| 27 | Mediastinal lymphadenopathy (HP:0100721) | 3.45846810 |
| 28 | Axonal loss (HP:0003447) | 3.45040127 |
| 29 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.43298455 |
| 30 | Mucopolysacchariduria (HP:0008155) | 3.43298455 |
| 31 | Myositis (HP:0100614) | 3.41321189 |
| 32 | Recurrent viral infections (HP:0004429) | 3.36274872 |
| 33 | Colitis (HP:0002583) | 3.28279439 |
| 34 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.24455916 |
| 35 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.24455916 |
| 36 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.24455916 |
| 37 | Gingivitis (HP:0000230) | 3.21571089 |
| 38 | Chronic obstructive pulmonary disease (HP:0006510) | 3.19727559 |
| 39 | Obstructive lung disease (HP:0006536) | 3.19727559 |
| 40 | Recurrent fungal infections (HP:0002841) | 3.18289906 |
| 41 | Thrombocytosis (HP:0001894) | 3.12474716 |
| 42 | Nephritis (HP:0000123) | 3.05588884 |
| 43 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.05495771 |
| 44 | Granulocytopenia (HP:0001913) | 2.99031747 |
| 45 | Hepatosplenomegaly (HP:0001433) | 2.98779032 |
| 46 | Chronic otitis media (HP:0000389) | 2.98309478 |
| 47 | Agnosia (HP:0010524) | 2.96788051 |
| 48 | Skin rash (HP:0000988) | 2.96138848 |
| 49 | Amyloidosis (HP:0011034) | 2.95372886 |
| 50 | Orchitis (HP:0100796) | 2.89486796 |
| 51 | Upper motor neuron abnormality (HP:0002127) | 2.87366888 |
| 52 | Agammaglobulinemia (HP:0004432) | 2.87094449 |
| 53 | Hematochezia (HP:0002573) | 2.86537789 |
| 54 | Meningitis (HP:0001287) | 2.83884199 |
| 55 | Pustule (HP:0200039) | 2.82192581 |
| 56 | Encephalitis (HP:0002383) | 2.81152644 |
| 57 | Severe combined immunodeficiency (HP:0004430) | 2.79057744 |
| 58 | J-shaped sella turcica (HP:0002680) | 2.78550282 |
| 59 | Chronic sinusitis (HP:0011109) | 2.78063605 |
| 60 | Autoimmune hemolytic anemia (HP:0001890) | 2.77777527 |
| 61 | Inflammation of the large intestine (HP:0002037) | 2.74169785 |
| 62 | Autoimmune thrombocytopenia (HP:0001973) | 2.73604169 |
| 63 | Osteomyelitis (HP:0002754) | 2.73169279 |
| 64 | Vasculitis (HP:0002633) | 2.68420626 |
| 65 | IgM deficiency (HP:0002850) | 2.63830200 |
| 66 | Recurrent pneumonia (HP:0006532) | 2.63795817 |
| 67 | Loss of speech (HP:0002371) | 2.59639937 |
| 68 | Abnormal platelet function (HP:0011869) | 2.58881855 |
| 69 | Impaired platelet aggregation (HP:0003540) | 2.58881855 |
| 70 | Microvesicular hepatic steatosis (HP:0001414) | 2.57859618 |
| 71 | Gastrointestinal inflammation (HP:0004386) | 2.54887802 |
| 72 | Hypergammaglobulinemia (HP:0010702) | 2.54119842 |
| 73 | Basal ganglia calcification (HP:0002135) | 2.53255559 |
| 74 | Spondylolisthesis (HP:0003302) | 2.52961141 |
| 75 | Stomatitis (HP:0010280) | 2.51687760 |
| 76 | Cerebral palsy (HP:0100021) | 2.50778200 |
| 77 | Interstitial pulmonary disease (HP:0006530) | 2.48913986 |
| 78 | Panhypogammaglobulinemia (HP:0003139) | 2.48159393 |
| 79 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.47199022 |
| 80 | Recurrent cutaneous fungal infections (HP:0011370) | 2.47199022 |
| 81 | Dicarboxylic aciduria (HP:0003215) | 2.47117927 |
| 82 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.47117927 |
| 83 | Thick nail (HP:0001805) | 2.44704024 |
| 84 | Periodontitis (HP:0000704) | 2.44569424 |
| 85 | Skin ulcer (HP:0200042) | 2.44011436 |
| 86 | Abnormality of T cell physiology (HP:0011840) | 2.42359853 |
| 87 | Spontaneous hematomas (HP:0007420) | 2.40843451 |
| 88 | Petechiae (HP:0000967) | 2.39964076 |
| 89 | Chest pain (HP:0100749) | 2.39575018 |
| 90 | Hypertensive crisis (HP:0100735) | 2.36926938 |
| 91 | Pulmonary infiltrates (HP:0002113) | 2.36253414 |
| 92 | Eosinophilia (HP:0001880) | 2.35674095 |
| 93 | 3-Methylglutaconic aciduria (HP:0003535) | 2.35360458 |
| 94 | Retrobulbar optic neuritis (HP:0100654) | 2.34432682 |
| 95 | Optic neuritis (HP:0100653) | 2.34432682 |
| 96 | Pathologic fracture (HP:0002756) | 2.33865858 |
| 97 | Chronic diarrhea (HP:0002028) | 2.33494172 |
| 98 | Ragged-red muscle fibers (HP:0003200) | 2.31809680 |
| 99 | Progressive neurologic deterioration (HP:0002344) | 2.31561549 |
| 100 | Thoracic kyphosis (HP:0002942) | 2.29857265 |
| 101 | Prostate neoplasm (HP:0100787) | 2.29011477 |
| 102 | Recurrent lower respiratory tract infections (HP:0002783) | 2.28118663 |
| 103 | Abnormality of the prostate (HP:0008775) | 2.25596612 |
| 104 | Combined immunodeficiency (HP:0005387) | 2.25573453 |
| 105 | Joint hemorrhage (HP:0005261) | 2.25226306 |
| 106 | Epistaxis (HP:0000421) | 2.24632262 |
| 107 | Urethral obstruction (HP:0000796) | 2.21691240 |
| 108 | Mutism (HP:0002300) | 2.20188718 |
| 109 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.19738704 |
| 110 | Viral hepatitis (HP:0006562) | 2.15638873 |
| 111 | Acute lymphatic leukemia (HP:0006721) | 2.13794528 |
| 112 | Leukocytosis (HP:0001974) | 2.09817659 |
| 113 | Gastrointestinal stroma tumor (HP:0100723) | 2.09313634 |
| 114 | Multiple enchondromatosis (HP:0005701) | 2.09139743 |
| 115 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 2.07079181 |
| 116 | Abnormality of the lumbar spine (HP:0100712) | 2.06995902 |
| 117 | Progressive microcephaly (HP:0000253) | 2.05117712 |
| 118 | Xerostomia (HP:0000217) | 2.04929172 |
| 119 | Prolonged bleeding time (HP:0003010) | 2.04859025 |
| 120 | Pulmonary fibrosis (HP:0002206) | 2.04750542 |
| 121 | Urticaria (HP:0001025) | 2.04452468 |
| 122 | Abnormality of male internal genitalia (HP:0000022) | 2.03841069 |
| 123 | Myocardial infarction (HP:0001658) | 2.03419897 |
| 124 | Deformed sella turcica (HP:0002681) | 2.02669073 |
| 125 | Reduced antithrombin III activity (HP:0001976) | 2.01944935 |
| 126 | Abnormality of the pleura (HP:0002103) | 2.01039129 |
| 127 | Retinal atrophy (HP:0001105) | 1.97473317 |
| 128 | Neutropenia (HP:0001875) | 1.96938270 |
| 129 | Arterial tortuosity (HP:0005116) | 1.96654952 |
| 130 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.95896787 |
| 131 | Osteolytic defects of the hand bones (HP:0009699) | 1.95896787 |
| 132 | Purpura (HP:0000979) | 1.94554063 |
| 133 | Apathy (HP:0000741) | 1.93395732 |
| 134 | Type I transferrin isoform profile (HP:0003642) | 1.93316912 |
| 135 | Mucosal telangiectasiae (HP:0100579) | 1.90704248 |
| 136 | Diminished motivation (HP:0000745) | 1.89582022 |
| 137 | Sepsis (HP:0100806) | 1.89286574 |
| 138 | Abnormality of T cells (HP:0002843) | 1.88025511 |
| 139 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.85249560 |
| 140 | Emphysema (HP:0002097) | 1.85123678 |
| 141 | Increased IgM level (HP:0003496) | 1.85122779 |
| 142 | Hypoplasia of the thymus (HP:0000778) | 1.83152955 |
| 143 | Recurrent bronchitis (HP:0002837) | 1.82569776 |
| 144 | Progressive visual loss (HP:0000529) | 1.81768091 |
| 145 | Lymphopenia (HP:0001888) | 1.81699592 |
| 146 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.77929349 |
| 147 | Villous atrophy (HP:0011473) | 1.77929349 |
| 148 | Gingival bleeding (HP:0000225) | 1.76689595 |
| 149 | Fatigue (HP:0012378) | 1.74577700 |
| 150 | Hepatocellular necrosis (HP:0001404) | 1.74357218 |
| 151 | Hemoptysis (HP:0002105) | 1.73885480 |
| 152 | Mesangial abnormality (HP:0001966) | 1.73118362 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BLK | 4.28846340 |
| 2 | TGFBR2 | 4.24938860 |
| 3 | MAP4K1 | 3.95255411 |
| 4 | TESK2 | 3.63858578 |
| 5 | TYK2 | 3.45736816 |
| 6 | RIPK4 | 3.26483833 |
| 7 | MAP3K14 | 2.98947057 |
| 8 | ERN1 | 2.98776092 |
| 9 | IRAK4 | 2.91064918 |
| 10 | CSF1R | 2.86521829 |
| 11 | VRK2 | 2.76677208 |
| 12 | KIT | 2.74476695 |
| 13 | TBK1 | 2.70687187 |
| 14 | KDR | 2.65068447 |
| 15 | NEK9 | 2.61960095 |
| 16 | GRK7 | 2.38640408 |
| 17 | TNK2 | 2.18308542 |
| 18 | STK10 | 2.02925120 |
| 19 | BCKDK | 2.01530820 |
| 20 | MAP3K11 | 1.99277448 |
| 21 | JAK1 | 1.98091976 |
| 22 | IKBKB | 1.93424931 |
| 23 | IRAK3 | 1.87158775 |
| 24 | SYK | 1.80745592 |
| 25 | PDK2 | 1.77931954 |
| 26 | ZAP70 | 1.77628790 |
| 27 | TXK | 1.77396095 |
| 28 | CLK1 | 1.70214563 |
| 29 | IKBKE | 1.60824778 |
| 30 | BTK | 1.56522841 |
| 31 | CSK | 1.55871193 |
| 32 | TEC | 1.53008564 |
| 33 | LYN | 1.51014436 |
| 34 | CDK19 | 1.50453843 |
| 35 | MATK | 1.46287261 |
| 36 | MAP2K3 | 1.42948634 |
| 37 | CDC7 | 1.42448007 |
| 38 | FES | 1.38524953 |
| 39 | HCK | 1.37962244 |
| 40 | TAOK3 | 1.32720412 |
| 41 | ITK | 1.29824440 |
| 42 | PIM2 | 1.27255889 |
| 43 | TESK1 | 1.23184980 |
| 44 | JAK3 | 1.21259392 |
| 45 | JAK2 | 1.17370105 |
| 46 | RPS6KA4 | 1.12375990 |
| 47 | LCK | 1.10121621 |
| 48 | MOS | 1.06320373 |
| 49 | MAPK7 | 1.01911971 |
| 50 | FGR | 1.01377236 |
| 51 | CDK4 | 0.97786094 |
| 52 | VRK1 | 0.93262510 |
| 53 | BMPR2 | 0.91563173 |
| 54 | CHUK | 0.86377996 |
| 55 | ARAF | 0.84098701 |
| 56 | MAPK12 | 0.82983041 |
| 57 | TRIB3 | 0.80498634 |
| 58 | PIM1 | 0.80100540 |
| 59 | CAMK1D | 0.79986611 |
| 60 | PKN2 | 0.79612161 |
| 61 | MAPK11 | 0.78714274 |
| 62 | EPHB1 | 0.77849860 |
| 63 | GRK6 | 0.76988013 |
| 64 | MAP3K13 | 0.76103030 |
| 65 | STK16 | 0.75566785 |
| 66 | PDK1 | 0.73409881 |
| 67 | DAPK1 | 0.69753044 |
| 68 | ZAK | 0.68473964 |
| 69 | ATR | 0.68440176 |
| 70 | PAK4 | 0.65366468 |
| 71 | CAMKK1 | 0.62983636 |
| 72 | RPS6KA6 | 0.61021049 |
| 73 | EGFR | 0.60828917 |
| 74 | CDK6 | 0.60414369 |
| 75 | PRKCD | 0.56137738 |
| 76 | TAOK1 | 0.54726380 |
| 77 | EIF2AK2 | 0.54292618 |
| 78 | RPS6KC1 | 0.53395648 |
| 79 | RPS6KL1 | 0.53395648 |
| 80 | FGFR4 | 0.53089395 |
| 81 | TRPM7 | 0.52570223 |
| 82 | MAPKAPK2 | 0.52303348 |
| 83 | BMX | 0.52119148 |
| 84 | MAPKAPK3 | 0.51998416 |
| 85 | FGFR3 | 0.51626286 |
| 86 | LIMK1 | 0.51118096 |
| 87 | MARK3 | 0.51063910 |
| 88 | RPS6KA5 | 0.49977357 |
| 89 | MAP3K1 | 0.49486930 |
| 90 | NME2 | 0.48778197 |
| 91 | CHEK2 | 0.48382519 |
| 92 | ABL1 | 0.46644367 |
| 93 | PRKCQ | 0.45922824 |
| 94 | RPS6KA2 | 0.45250583 |
| 95 | HIPK2 | 0.44972948 |
| 96 | PLK4 | 0.44636871 |
| 97 | LRRK2 | 0.44043626 |
| 98 | STK4 | 0.42462140 |
| 99 | CSNK1G3 | 0.41986347 |
| 100 | IGF1R | 0.41868649 |
| 101 | PRKD1 | 0.41822584 |
| 102 | PDPK1 | 0.41808367 |
| 103 | PTK6 | 0.40665743 |
| 104 | EEF2K | 0.40522640 |
| 105 | CDK7 | 0.39262581 |
| 106 | CCNB1 | 0.39154299 |
| 107 | TAOK2 | 0.39145670 |
| 108 | SCYL2 | 0.38863847 |
| 109 | MAPK15 | 0.38760427 |
| 110 | SIK2 | 0.38554258 |
| 111 | MAP3K10 | 0.38304477 |
| 112 | CAMK1G | 0.37936943 |
| 113 | PIK3CG | 0.37906611 |
| 114 | MAPK13 | 0.37267452 |
| 115 | GRK5 | 0.36790725 |
| 116 | TLK1 | 0.36542370 |
| 117 | MAPK3 | 0.33672884 |
| 118 | CAMKK2 | 0.33023095 |
| 119 | PRKD2 | 0.32910498 |
| 120 | ABL2 | 0.32845489 |
| 121 | MAP3K6 | 0.32708868 |
| 122 | FYN | 0.32489236 |
| 123 | ADRBK2 | 0.31742296 |
| 124 | FLT3 | 0.31339952 |
| 125 | AURKA | 0.31007947 |
| 126 | RPS6KB2 | 0.30344140 |
| 127 | YES1 | 0.28708998 |
| 128 | MAPK4 | 0.28532576 |
| 129 | MAP4K2 | 0.27882602 |
| 130 | CDK8 | 0.25002095 |
| 131 | MAP3K3 | 0.24539116 |
| 132 | TTN | 0.24524157 |
| 133 | SGK3 | 0.23716125 |
| 134 | MAP3K8 | 0.23121784 |
| 135 | NEK6 | 0.21367934 |
| 136 | CDK9 | 0.21170327 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 4.26551539 |
| 2 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 3.97786260 |
| 3 | Other glycan degradation_Homo sapiens_hsa00511 | 3.74267034 |
| 4 | DNA replication_Homo sapiens_hsa03030 | 3.39185516 |
| 5 | Lysosome_Homo sapiens_hsa04142 | 3.28110968 |
| 6 | Leishmaniasis_Homo sapiens_hsa05140 | 3.08450300 |
| 7 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.75109944 |
| 8 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.70632120 |
| 9 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.37437339 |
| 10 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.35044071 |
| 11 | Pertussis_Homo sapiens_hsa05133 | 2.24403503 |
| 12 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.18936842 |
| 13 | Tuberculosis_Homo sapiens_hsa05152 | 2.18889245 |
| 14 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.14265260 |
| 15 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.03946974 |
| 16 | Legionellosis_Homo sapiens_hsa05134 | 1.86710991 |
| 17 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.83455237 |
| 18 | Mismatch repair_Homo sapiens_hsa03430 | 1.80489448 |
| 19 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.77512724 |
| 20 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.66589366 |
| 21 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.65095776 |
| 22 | Malaria_Homo sapiens_hsa05144 | 1.62278043 |
| 23 | Measles_Homo sapiens_hsa05162 | 1.61376904 |
| 24 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.59606037 |
| 25 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.59129818 |
| 26 | Homologous recombination_Homo sapiens_hsa03440 | 1.55936949 |
| 27 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.55023874 |
| 28 | Phagosome_Homo sapiens_hsa04145 | 1.54275483 |
| 29 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.51832714 |
| 30 | Salmonella infection_Homo sapiens_hsa05132 | 1.43216308 |
| 31 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.41523473 |
| 32 | Influenza A_Homo sapiens_hsa05164 | 1.40835798 |
| 33 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.40750215 |
| 34 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.40427640 |
| 35 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.34824054 |
| 36 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.34634967 |
| 37 | Apoptosis_Homo sapiens_hsa04210 | 1.33262153 |
| 38 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.31581203 |
| 39 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.30923694 |
| 40 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.30810271 |
| 41 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.27557813 |
| 42 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.27244157 |
| 43 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.21358943 |
| 44 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.21262546 |
| 45 | Shigellosis_Homo sapiens_hsa05131 | 1.18323011 |
| 46 | Platelet activation_Homo sapiens_hsa04611 | 1.17017083 |
| 47 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.14278919 |
| 48 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.10407439 |
| 49 | Asthma_Homo sapiens_hsa05310 | 1.08147530 |
| 50 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.06351116 |
| 51 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.03863563 |
| 52 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.02880924 |
| 53 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.98127932 |
| 54 | Allograft rejection_Homo sapiens_hsa05330 | 0.98025369 |
| 55 | Ribosome_Homo sapiens_hsa03010 | 0.97740182 |
| 56 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.97403345 |
| 57 | Hepatitis B_Homo sapiens_hsa05161 | 0.95558219 |
| 58 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.92188150 |
| 59 | Prion diseases_Homo sapiens_hsa05020 | 0.91304179 |
| 60 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.89965639 |
| 61 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.87853489 |
| 62 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.85752891 |
| 63 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.84278031 |
| 64 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.81249120 |
| 65 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.77192218 |
| 66 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.76387158 |
| 67 | Viral myocarditis_Homo sapiens_hsa05416 | 0.76182309 |
| 68 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.74697268 |
| 69 | Hepatitis C_Homo sapiens_hsa05160 | 0.74054331 |
| 70 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.72670034 |
| 71 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.64031040 |
| 72 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.62979647 |
| 73 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.61892200 |
| 74 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.60522654 |
| 75 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.59419550 |
| 76 | RNA polymerase_Homo sapiens_hsa03020 | 0.57683316 |
| 77 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.53303240 |
| 78 | Amoebiasis_Homo sapiens_hsa05146 | 0.53209788 |
| 79 | Endocytosis_Homo sapiens_hsa04144 | 0.51629535 |
| 80 | Proteasome_Homo sapiens_hsa03050 | 0.50963300 |
| 81 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.50778570 |
| 82 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.50015166 |
| 83 | Sulfur relay system_Homo sapiens_hsa04122 | 0.48321996 |
| 84 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.48281130 |
| 85 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.48159309 |
| 86 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.47562918 |
| 87 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.46546377 |
| 88 | Parkinsons disease_Homo sapiens_hsa05012 | 0.46112671 |
| 89 | Purine metabolism_Homo sapiens_hsa00230 | 0.44118849 |
| 90 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.41768317 |
| 91 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.40885422 |
| 92 | Spliceosome_Homo sapiens_hsa03040 | 0.40552537 |
| 93 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.40406013 |
| 94 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.39888968 |
| 95 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.37566606 |
| 96 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.37467729 |
| 97 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.37188637 |
| 98 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.36569808 |
| 99 | ABC transporters_Homo sapiens_hsa02010 | 0.35801955 |
| 100 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.35692246 |
| 101 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.34627509 |
| 102 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.33967775 |
| 103 | Base excision repair_Homo sapiens_hsa03410 | 0.32408373 |
| 104 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.31752975 |
| 105 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.30625397 |
| 106 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.30350554 |
| 107 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.30071658 |
| 108 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.29614988 |
| 109 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.28755777 |
| 110 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.28722666 |
| 111 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.28636930 |
| 112 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.24062276 |
| 113 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.23200073 |
| 114 | Colorectal cancer_Homo sapiens_hsa05210 | 0.22730297 |
| 115 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.21628349 |
| 116 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.21325877 |
| 117 | HTLV-I infection_Homo sapiens_hsa05166 | 0.20758608 |
| 118 | Peroxisome_Homo sapiens_hsa04146 | 0.20337407 |
| 119 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.19851658 |
| 120 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.19382323 |
| 121 | Alcoholism_Homo sapiens_hsa05034 | 0.18462519 |
| 122 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.18141633 |
| 123 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.17194268 |
| 124 | Huntingtons disease_Homo sapiens_hsa05016 | 0.16154040 |
| 125 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.15697110 |
| 126 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.15366439 |
| 127 | Alzheimers disease_Homo sapiens_hsa05010 | 0.14924548 |
| 128 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.14387309 |
| 129 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.13398248 |
| 130 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.12398846 |
| 131 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.11615476 |
| 132 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.11506820 |
| 133 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.08691663 |
| 134 | Cell cycle_Homo sapiens_hsa04110 | 0.06606819 |

